Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	cell surface	NID2 CD248 NLGN4Y TRPC4 ITGA4 ITGA9 ITGB4 DIP2A NLGN4X SEMA6D PTPRK IGHD SLC34A1 IGHM TEX101 LRP2 KCNN2 FCRLB ABCB11 PAM GPC5 BSN BTNL9 TNS1	1.06e-05	1111	169	24	GO:0009986
GeneOntologyCellularComponent	B cell receptor complex	IGHD IGHE IGHM	2.82e-05	8	169	3	GO:0019815
GeneOntologyCellularComponent	inhibitory synapse	NLGN4Y NLGN4X IGSF9 BSN	1.09e-04	31	169	4	GO:0060077
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN4X	3.86e-04	4	169	2	GO:0098983
GeneOntologyCellularComponent	basement membrane	NID2 HSPG2 COL7A1 LAMA5 ITGB4 HMCN2	4.76e-04	122	169	6	GO:0005604
Domain	Growth_fac_rcpt_	NID2 HSPG2 CD248 INSRR LAMA5 FAT1 HMCN2 LRP2	6.59e-05	156	162	8	IPR009030
Domain	NLGN4	NLGN4Y NLGN4X	7.48e-05	2	162	2	IPR030025
Pathway	REACTOME_LAMININ_INTERACTIONS	NID2 HSPG2 COL7A1 LAMA5 ITGB4	3.68e-06	30	113	5	M27216
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 HSPG2 PDE2A SZT2 MYO9B LAMA5 TWNK FRYL MED13L DYSF PRAG1 ITGB4 PHC2 SH3BP4 HDDC3 DIP2A RADIL FAT1 LATS2 NISCH DIP2C DTX2 TRIB1 WNK2 SYMPK	2.54e-10	1105	172	25	35748872
Pubmed	Synergistic activities of alpha3 and alpha6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse.	HSPG2 LAMA5 ITGB4 MSX1	2.77e-07	12	172	4	10433923
Pubmed	EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation.	NID2 ITGA4 ITGA9 ITGB4	5.56e-07	14	172	4	21949412
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MON2 HDAC5 URB2 MED13L KLHL29 GANAB SEMA6D NISCH PACS2 SEZ6L DOP1B PDZD2	9.87e-07	407	172	12	12693553
Pubmed	PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα.	HSPG2 COL7A1 LAMA5 ITGB4	3.24e-06	21	172	4	27856617
Pubmed	alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.	COL7A1 LAMA5 ITGB4	4.10e-06	7	172	3	9151677
Pubmed	Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.	HSPG2 ITGA4 ITGA9 ITGB4	9.28e-06	27	172	4	31541017
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	DHX37 ACAD10 MED13L TRIP13 ZFX CHMP7 GMEB1 PAM CPLANE1 TRIB1 DOP1B	1.10e-05	431	172	11	33660365
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	NID2 HSPG2 COL7A1 LAMA5	1.25e-05	29	172	4	22613833
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	LAMA5 ELFN2 KLHL29 FAM111A CSMD1	1.56e-05	63	172	5	11572484
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CYP4V2 MARS1 NLGN4Y PPFIBP2 FRYL SLC10A7 PTPN18 TRIP13 SH3BP4 KLHL29 LATS2 FAM111A ATXN1 EIF2B4 KCNN2 DIP2C IGSF9 CSMD1 PLOD1 WNK2 PDZD2	1.61e-05	1489	172	21	28611215
Pubmed	ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.	HSPG2 LAMA5 ITGA4 ITGB4	1.64e-05	31	172	4	22274697
Pubmed	Loss of nidogen-1 and -2 results in syndactyly and changes in limb development.	NID2 HSPG2 ITGB4	1.90e-05	11	172	3	17023412
Pubmed	Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.	LAMA5 LATS1 LATS2	1.90e-05	11	172	3	33515576
Pubmed	Laminin 5 binds the NC-1 domain of type VII collagen.	COL7A1 LAMA5	2.43e-05	2	172	2	9245798
Pubmed	Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.	LATS1 LATS2	2.43e-05	2	172	2	25482410
Pubmed	Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts.	CYP19A1 RET	2.43e-05	2	172	2	27602955
Pubmed	Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog.	DIP2A DIP2C	2.43e-05	2	172	2	12137943
Pubmed	Diversity and joining segments of mouse immunoglobulin heavy chain genes are closely linked and in the same orientation: implications for the joining mechanism.	IGHD IGHM	2.43e-05	2	172	2	6407007
Pubmed	Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells.	LATS1 LATS2	2.43e-05	2	172	2	30671453
Pubmed	Simultaneous expression of immunoglobulin mu and delta heavy chains by a cloned B-cell lymphoma: a single copy of the VH gene is shared by two adjacent CH genes.	IGHD IGHM	2.43e-05	2	172	2	6806821
Pubmed	A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.	LATS1 LATS2	2.43e-05	2	172	2	32826458
Pubmed	IgD can largely substitute for loss of IgM function in B cells.	IGHD IGHM	2.43e-05	2	172	2	9655395
Pubmed	AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.	LATS1 LATS2	2.43e-05	2	172	2	29730476
Pubmed	The junctional epithelium originates from the odontogenic epithelium of an erupted tooth.	LAMA5 ITGB4	2.43e-05	2	172	2	24785116
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	2.43e-05	2	172	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	2.43e-05	2	172	2	24855039
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	2.43e-05	2	172	2	37001827
Pubmed	N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.	LATS1 LATS2	2.43e-05	2	172	2	23230145
Pubmed	Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis.	LAMA5 ITGA4	2.43e-05	2	172	2	38154529
Pubmed	LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.	LATS1 LATS2	2.43e-05	2	172	2	31848340
Pubmed	Expression of LATS family proteins in ovarian tumors and its significance.	LATS1 LATS2	2.43e-05	2	172	2	25841306
Pubmed	Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.	LATS1 LATS2	2.43e-05	2	172	2	24026096
Pubmed	BAG3 affects the nucleocytoplasmic shuttling of HSF1 upon heat stress.	BAG3 HSF1	2.43e-05	2	172	2	26159920
Pubmed	High-resolution maps of the murine Chromosome 2 region containing the cholesterol gallstone locus, Lith1.	LRP2 ABCB11	2.43e-05	2	172	2	10556425
Pubmed	Bag3 gene expression is regulated by heat shock factor 1.	BAG3 HSF1	2.43e-05	2	172	2	18286539
Pubmed	Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.	LATS1 LATS2	2.43e-05	2	172	2	32423384
Pubmed	Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma.	LATS1 LATS2	2.43e-05	2	172	2	34060480
Pubmed	Alpha4beta1 integrin acts as a cell receptor for murine polyomavirus at the postattachment level.	ITGA4 ITGB4	2.43e-05	2	172	2	12634351
Pubmed	Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.	LATS1 LATS2	2.43e-05	2	172	2	17049657
Pubmed	BAG3 expression and sarcomere localization in the human heart are linked to HSF-1 and are differentially affected by sex and disease.	BAG3 HSF1	2.43e-05	2	172	2	33989081
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	2.43e-05	2	172	2	18434543
Pubmed	Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.	LATS1 LATS2	2.43e-05	2	172	2	31268774
Pubmed	The Hippo pathway regulates human megakaryocytic differentiation.	LATS1 LATS2	2.43e-05	2	172	2	27786336
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	2.43e-05	2	172	2	37080762
Pubmed	Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation.	BAG3 MVP	2.43e-05	2	172	2	24997994
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	2.43e-05	2	172	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	2.43e-05	2	172	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	2.43e-05	2	172	2	24104404
Pubmed	Cell type-dependent function of LATS1/2 in cancer cell growth.	LATS1 LATS2	2.43e-05	2	172	2	30531839
Pubmed	Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.	LATS1 LATS2	2.43e-05	2	172	2	15746036
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4Y NLGN4X	2.43e-05	2	172	2	32243781
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	2.43e-05	2	172	2	22989184
Pubmed	Responsiveness of B cells is regulated by the hinge region of IgD.	IGHD IGHM	2.43e-05	2	172	2	25848865
Pubmed	Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.	LATS1 LATS2	2.43e-05	2	172	2	19799973
Pubmed	Type VII collagen is required for Ras-driven human epidermal tumorigenesis.	COL7A1 LAMA5	2.43e-05	2	172	2	15774758
Pubmed	LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control.	LATS1 LATS2	2.43e-05	2	172	2	32015438
Pubmed	A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.	LATS1 LATS2	2.43e-05	2	172	2	25044019
Pubmed	PLOD1 acts as a tumor promoter in glioma via activation of the HSF1 signaling pathway.	HSF1 PLOD1	2.43e-05	2	172	2	34845571
Pubmed	2'-Hydroxycinnamaldehyde induces apoptosis through HSF1-mediated BAG3 expression.	BAG3 HSF1	2.43e-05	2	172	2	27922674
Pubmed	Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids.	LAMA5 ITGA9 ITGB4	2.53e-05	12	172	3	10090148
Pubmed	Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis.	HSPG2 COL7A1 LAMA5 MSX1	2.68e-05	35	172	4	18676816
Pubmed	Basement membranes in skin are differently affected by lack of nidogen 1 and 2.	NID2 HSPG2 ITGB4	3.28e-05	13	172	3	18356808
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DMXL2 ZBTB2 ZNF407 ELFN2 RADIL RAB3GAP1 VPS13D MYO15B DISP3 DIP2C DTX2	3.78e-05	493	172	11	15368895
Pubmed	Membrane-type MMPs are indispensable for placental labyrinth formation and development.	NID2 HSPG2 LAMA5	4.16e-05	14	172	3	20858856
Pubmed	Structure and function of immunoglobulins.	IGHD IGHE IGHM	5.18e-05	15	172	3	20176268
Pubmed	Basement membrane composition in the early mouse embryo day 7.	NID2 HSPG2 LAMA5	5.18e-05	15	172	3	15895400
Pubmed	Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation.	HSPG2 LAMA5 ITGB4	6.35e-05	16	172	3	21067603
Pubmed	A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.	LATS1 LATS2	7.27e-05	3	172	2	30308519
Pubmed	Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population.	VPS13D CSMD1	7.27e-05	3	172	2	20610895
Pubmed	Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.	LATS1 LATS2	7.27e-05	3	172	2	24012335
Pubmed	CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1.	DIP2A DIP2C	7.27e-05	3	172	2	17236128
Pubmed	LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells.	LATS1 LATS2	7.27e-05	3	172	2	35859006
Pubmed	Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia.	LRP2 HSF1	7.27e-05	3	172	2	27518433
Pubmed	Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5.	LAMA5 ITGB4	7.27e-05	3	172	2	15316072
Pubmed	Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin.	ITGA4 ITGA9	7.27e-05	3	172	2	23192608
Pubmed	Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.	DYSF MYOM2	7.27e-05	3	172	2	23792176
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4Y NLGN4X	7.27e-05	3	172	2	32011705
Pubmed	PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma.	LATS1 PLOD1	7.27e-05	3	172	2	32446383
Pubmed	Identification of endogenous retroviral reading frames in the human genome.	ERVK-10 ERVFRD-1	7.27e-05	3	172	2	15476554
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4Y NLGN4X	7.27e-05	3	172	2	18628683
Pubmed	Regulation of cell migration by α4 and α9 integrins.	ITGA4 ITGA9	7.27e-05	3	172	2	30819933
Pubmed	Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.	LATS1 LATS2	7.27e-05	3	172	2	18413746
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4Y NLGN4X	7.27e-05	3	172	2	21282647
Pubmed	A novel rabconnectin-3-binding protein that directly binds a GDP/GTP exchange protein for Rab3A small G protein implicated in Ca(2+)-dependent exocytosis of neurotransmitter.	DMXL2 RAB3GAP1	7.27e-05	3	172	2	12786944
Pubmed	Mon2, a relative of large Arf exchange factors, recruits Dop1 to the Golgi apparatus.	MON2 DOP1B	7.27e-05	3	172	2	16301316
Pubmed	Tumor suppressor LATS1 is a negative regulator of oncogene YAP.	LATS1 LATS2	7.27e-05	3	172	2	18158288
Pubmed	Intraperitoneal administration of recombinant receptor-associated protein causes phosphaturia via an alteration in subcellular distribution of the renal sodium phosphate co-transporter.	SLC34A1 LRP2	7.27e-05	3	172	2	15976002
Pubmed	Impaired PTH-induced endocytotic down-regulation of the renal type IIa Na+/Pi-cotransporter in RAP-deficient mice with reduced megalin expression.	SLC34A1 LRP2	7.27e-05	3	172	2	12748857
Pubmed	HSF1 modulation of Hsp70 mRNA polyadenylation via interaction with symplekin.	HSF1 SYMPK	7.27e-05	3	172	2	14707147
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	BCORL1 PPFIA3 OR51L1 TMEM260 DIP2A OTC MYO15B DROSHA BTD RECQL4 LRP2 DOP1B SYMPK	8.24e-05	736	172	13	29676528
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	MON2 NID2 HSPG2 CD248 ACO1 LAMA5 DYSF GANAB IGHD BTD IGHM LRP2 PAM BPIFB2 TMC5 DOP1B	8.91e-05	1070	172	16	23533145
Pubmed	Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.	LAMA5 ITGA4 ITGA9	9.18e-05	18	172	3	19686679
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SMG1 COL7A1 SZT2 MYO9B HEATR1 KLHL29 FAT1 MYO15B BTD CPLANE1 TNS1	1.03e-04	552	172	11	10737800
Pubmed	Expression patterns of the aquaporin gene family during renal development: influence of genetic variability.	AQP7P3 SLC34A1 LRP2	1.09e-04	19	172	3	19367412
Pubmed	Abnormal Wnt and PI3Kinase signaling in the malformed intestine of lama5 deficient mice.	LAMA5 ITGB4 MSX1	1.09e-04	19	172	3	22666383
Pubmed	αE-catenin inhibits YAP/TAZ activity to regulate signalling centre formation during tooth development.	MSX1 LATS1 LATS2	1.09e-04	19	172	3	27405641
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	CYP4V2 ABHD14A SPPL3 TMEM207 PIGU IL22RA2 NLGN4X TEX101 IGSF9 BPIFB2 CSMD1 TMC5 BTNL9 SEZ6L ERVFRD-1	1.22e-04	985	172	15	12975309
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SMG1 DMXL2 HDAC5 PPFIA3 MED13L DIP2C DOP1B	1.37e-04	225	172	7	12168954
Pubmed	Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.	LATS1 LATS2	1.45e-04	4	172	2	28754671
Cytoband	1p36.22	VPS13D DISP3 PLOD1	3.66e-04	37	172	3	1p36.22
Cytoband	6q25.1	ZBTB2 LATS1 IL22RA2	3.96e-04	38	172	3	6q25.1
Cytoband	3p21.1	ABHD14A COL7A1 NISCH	5.33e-04	42	172	3	3p21.1
GeneFamily	Fibronectin type III domain containing	COL7A1 INSRR ELFN2 ITGB4 PTPRK IGSF9 MYOM2	4.10e-05	160	105	7	555
GeneFamily	Cadherin related	RET FAT1 DCHS1	1.22e-04	17	105	3	24
GeneFamily	Immunoglobulin like domain containing	HSPG2 HMCN2 PTPRK FCRLB IGSF9 MYOM2	9.18e-04	193	105	6	594
Coexpression	YAGI_AML_WITH_11Q23_REARRANGED	HSPG2 DMXL2 DEXI IMPG1 RET MED13L IDS NKX2-8 VPS13D ATXN1 EIF2B4 DIP2C DOP1B	3.24e-07	346	165	13	M17123
Coexpression	GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN	FAM234B PDE2A SQLE BAG3 CHMP7 RAB3GAP1 PACS2 ABHD1 MVP	5.26e-06	200	165	9	M6273
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MON2 DMXL2 FRYL HEATR1 ITGA4 SLC10A7 IFT80 DOP1B	6.09e-07	185	171	8	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MON2 DMXL2 FRYL HEATR1 ITGA4 SLC10A7 IFT80 DOP1B	6.35e-07	186	171	8	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL7A1 SLC9A9 DSG3 LAMA5 ITGB4 KLHL29 CSMD1 TNS1	1.06e-06	199	171	8	94a7867e800df352731796de8c24cba133c29622
ToppCell	CV-Healthy-3\|CV / Virus stimulation, Condition and Cluster	DEXI PPFIBP2 SPPL3 ACAD10 ITGB4 EIF2B4 MVP	3.02e-06	161	171	7	fd4a79385ea967b9900dc76a3add813b894a3a28
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPIPB15 ACO1 SLC25A34 BCORL1 MYO15B PTPRK IGHD	5.23e-06	175	171	7	87e557f7508c88b2087db5d57e77d5e2c92ca083
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PDE2A ITGA9 DYSF LRRC55 DCHS1 BTNL9	6.07e-06	179	171	7	8f9e538c822940785130297712b75131812a4603
ToppCell	droplet-Fat-Gat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A DYSF PRAG1 DCHS1 PLOD1 BTNL9 TNS1	6.07e-06	179	171	7	08cf9986804a6417a9afb19b50c69a3554f71ec6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	C5orf67 SLC25A34 SLC13A1 LRP2 KIAA1755 CSMD1 PDZD2	7.02e-06	183	171	7	85446581999cd66b171c4f69b7eb8b0bbbaa8617
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD248 NLGN4Y PPFIBP2 FAT1 SEMA6D GPC5 PDZD2	7.27e-06	184	171	7	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD248 PPFIBP2 ITGA4 FAT1 SEMA6D GPC5 PDZD2	7.27e-06	184	171	7	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	Endothelial-A-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	HSPG2 PDE2A DYSF ITGB4 OTC DCHS1 BTNL9	7.53e-06	185	171	7	dee0b7ba2f338f0979d2306aedf52ac35a36b60c
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE2A ITGA9 DYSF PKHD1L1 ITGB4 RADIL NLGN4X	8.66e-06	189	171	7	55a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 PDE2A ITGA9 PKHD1L1 PLOD1 BTNL9 SEZ6L	9.27e-06	191	171	7	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	COL7A1 DSG3 NLGN4Y LAMA5 ITGB4 FAT1 IGSF9	9.27e-06	191	171	7	a98915bad9a4a61dd4cbca798914849b805f4a19
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 PDE2A ITGA9 PKHD1L1 PLOD1 BTNL9 SEZ6L	9.27e-06	191	171	7	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	MON2 SPPL3 FAXDC2 MED13L PRAG1 PTPRK PRAME	9.59e-06	192	171	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF407 MED13L PTPRK ATXN1 DIP2C GPC5 PDZD2	1.10e-05	196	171	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF407 MED13L PTPRK ATXN1 DIP2C GPC5 PDZD2	1.17e-05	198	171	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A ITGA9 DYSF PKHD1L1 RADIL CYB5R3 TNS1	1.17e-05	198	171	7	99d6a64f3410dae3019161feef20a8f06081a24b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DRAM1 PTPRK LRP2 GPC5 TMC5 LRRC36 PDZD2	1.21e-05	199	171	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PTPRK IGHD IGHE IGHM TMC5 BTNL9	2.61e-05	151	171	6	2314c004434aed9b7fa1ad01c61c43e5ed4a18ce
ToppCell	CV-Healthy-3\|Healthy / Virus stimulation, Condition and Cluster	DEXI SPPL3 ACAD10 ITGB4 EIF2B4 KLHL42	2.91e-05	154	171	6	26bf81a86700db7e65c2384ffe94ed4253ea4047
ToppCell	390C-Epithelial_cells-Epithelial-A_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE2A CD248 RADIL HMCN2 BSN	3.82e-05	98	171	5	a74fb790c135bd0d0033df3aca7b789d8b25e361
ToppCell	390C-Epithelial_cells-Epithelial-A_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE2A CD248 RADIL HMCN2 BSN	3.82e-05	98	171	5	cb0941481aef9068d7dbce0d1b6cf125f482a98d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADAD1 HSPG2 PDE2A DSG3 DYSF TEX101	3.87e-05	162	171	6	5428c9fdb816f564395ebb4520448e5f3a42b025
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PDE2A TMEM207 RET LRRC55 NISCH BSN	4.43e-05	166	171	6	6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC34A1 LRP2 CSMD1 TMC5 SEZ6L PDZD2	4.58e-05	167	171	6	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	Control\|World / group, cell type (main and fine annotations)	PTPRK LRP2 GPC5 TMC5 LRRC36 PDZD2	4.74e-05	168	171	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)\|368C / Donor, Lineage, Cell class and subclass (all cells)	PDE2A ITGA9 DYSF PKHD1L1 ITGB4 WNK2	4.74e-05	168	171	6	a74c8a9e3299183fba31ce3053ef325b5dbcd104
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	PDE2A ITGA9 DYSF PKHD1L1 ITGB4 WNK2	4.74e-05	168	171	6	dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 DEXI ACAD10 KLHL29 HSF1 WNK2	5.58e-05	173	171	6	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 DEXI ACAD10 KLHL29 HSF1 WNK2	5.58e-05	173	171	6	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NLGN4Y RET IGHE KCNN2 GPC5 SEZ6L	5.76e-05	174	171	6	16204ff504b7b382b4d90ca35003ad5336020e07
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	SMG1 NLGN4Y ZNF407 HEATR1 ITGA4 PAM	6.13e-05	176	171	6	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC9A9 PDE2A ITGA9 PKHD1L1 DCHS1 PRAME	6.33e-05	177	171	6	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	P28-Endothelial-lymphatic_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NID2 PDE2A ITGA9 PTPN18 PKHD1L1 BTNL9	6.33e-05	177	171	6	6e330aa3c87fd640526b746a9deb3b2250d2518c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC9A9 PDE2A ITGA9 PKHD1L1 DCHS1 PRAME	6.33e-05	177	171	6	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	C5orf67 SLC13A1 LRP2 KIAA1755 CSMD1 PDZD2	6.33e-05	177	171	6	2f81b26be89cc2fd8eafadaf7eae3c6ad6521462
ToppCell	P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NID2 PDE2A ITGA9 PTPN18 PKHD1L1 BTNL9	6.33e-05	177	171	6	e96a7e4544710aaab8bd2800ecff9667880a8bf4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC9A9 PDE2A ITGA9 PKHD1L1 DCHS1 PRAME	6.33e-05	177	171	6	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ITGA4 ITGA9 PRAG1 PTPRK KCNN2 PDZD2	6.53e-05	178	171	6	ccea3c8908d72f5fecd151a133048c8e9758304c
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL7A1 CD248 KLHL29 FAT1 SEMA6D KIAA1755	6.73e-05	179	171	6	98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCell	3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM234B ITGA9 DYSF PKHD1L1 RADIL CYB5R3	6.73e-05	179	171	6	ec1d7017da325647b629de703135a404bbdc627d
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	PDE2A ITGA9 DYSF PKHD1L1 ITGB4 RADIL	7.16e-05	181	171	6	b244ecaa442bbef51289d8ec574ef08fa9e96318
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A ITGA9 DYSF PKHD1L1 BSN BTNL9	7.16e-05	181	171	6	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)\|367C / Donor, Lineage, Cell class and subclass (all cells)	PDE2A ITGA9 DYSF PKHD1L1 ITGB4 RADIL	7.16e-05	181	171	6	dd79de8098edb385a0f85d0e9621503cdf76ec43
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	C5orf67 SLC34A1 LRP2 GPC5 CSMD1 PDZD2	7.16e-05	181	171	6	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	10x5'-Liver-Lymphocytic_B-Memory_B_cells\|Liver / Manually curated celltypes from each tissue	PPFIBP2 PKHD1L1 NLGN4X IGHE IGHM BTNL9	7.16e-05	181	171	6	a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A ITGA9 DYSF PKHD1L1 BSN BTNL9	7.16e-05	181	171	6	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A ITGA9 DYSF PKHD1L1 BSN BTNL9	7.16e-05	181	171	6	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AHI1-DT SIM2 PRAG1 NLGN4X SEMA6D GPC5	7.38e-05	182	171	6	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ITGA9 SH3BP4 FAT1 DTX2 TMC5 WNK2	7.38e-05	182	171	6	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	Basal\|World / shred by cell class for mouse tongue	COL7A1 DRAM1 LAMA5 ITGB4 CYB5R3 TNS1	7.61e-05	183	171	6	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD248 NLGN4Y PPFIBP2 SEMA6D GPC5 PDZD2	7.61e-05	183	171	6	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 FAT1 DISP3 LRP2 MYOM2 CSMD1	7.84e-05	184	171	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	PTPRK LRP2 GPC5 TMC5 MUCL3 PDZD2	7.84e-05	184	171	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 FAT1 DISP3 LRP2 MYOM2 CSMD1	7.84e-05	184	171	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 FAT1 DISP3 LRP2 MYOM2 CSMD1	7.84e-05	184	171	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Liver-Npc-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A9 PDE2A ZNF407 FANCF DCHS1 ABHD1	8.32e-05	186	171	6	75258d88e23112fd1f0f7c71ef0366abb400d33e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	C5orf67 SLC13A1 LRP2 KIAA1755 CSMD1 PDZD2	8.32e-05	186	171	6	a417e1e21313a7e05951038cdef5ac672a9f727c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 AHI1-DT SIM2 DIP2C TNS1 PDZD2	8.32e-05	186	171	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PKHD1L1 SLC13A1 SLC34A1 LRP2	8.32e-05	60	171	4	aa75fef294803ec6396c7d2c1f51d52bc4a5b43f
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PKHD1L1 SLC13A1 SLC34A1 LRP2	8.32e-05	60	171	4	069fbabfd0e48e5809ff01a026439fd0bd017779
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 AHI1-DT SIM2 DIP2C TNS1 PDZD2	8.57e-05	187	171	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PKHD1L1 IL22RA2 SLC22A14 LRP2 RBM46	8.57e-05	187	171	6	4e553721fa5598cb211f44e3226280b7e6885484
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PKHD1L1 IL22RA2 SLC22A14 LRP2 RBM46	8.57e-05	187	171	6	d36e7fc6125e7a4310499365022d38f34b757a73
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 PKHD1L1 IL22RA2 SLC22A14 LRP2 RBM46	8.57e-05	187	171	6	827eae63fabf6892a82ce7779b5f395958d3d628
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 ITGB4 SH3BP4 MSX1 DISP3 CSMD1	9.09e-05	189	171	6	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	LAMA5 RADIL DIP2C GPC5 TMC5 PDZD2	9.09e-05	189	171	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	LPS-IL1RA-Unknown-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD248 NLGN4Y PRAG1 E2F8 KCNN2	9.25e-05	118	171	5	aefad0b35aff980b6a2a98057735442e8a65ab04
ToppCell	LPS-IL1RA-Unknown\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD248 NLGN4Y PRAG1 E2F8 KCNN2	9.25e-05	118	171	5	6cb4063b83f867b782080ce5b1199b51bb277f2a
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	COL7A1 DSG3 LAMA5 ITGB4 FAT1 PTPRK	9.35e-05	190	171	6	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	21-Trachea-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	HSPG2 PDE2A ITGA9 DYSF LRRC55 DCHS1	9.35e-05	190	171	6	bce09634acbc2cfd53666328e8aed8bf8835f845
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 PDE2A ITGA9 PKHD1L1 PLOD1 BTNL9	9.35e-05	190	171	6	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA9 ELFN2 SH3BP4 GPC5 CSMD1 SEZ6L	9.35e-05	190	171	6	9b825b2586c7b173ff27fcf2abc5860faf50984a
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 ITGA9 PKHD1L1 ITGB4 KLHL29 DCHS1	9.35e-05	190	171	6	3cf464664d6aa22b212e60b70885953887e92483
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 PDE2A ITGA9 PKHD1L1 PLOD1 BTNL9	9.35e-05	190	171	6	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	21-Trachea-Endothelial-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	HSPG2 PDE2A ITGA9 DYSF LRRC55 DCHS1	9.35e-05	190	171	6	08437396a98ca9526f69c3a74bbf2929f3c68b8e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA9 ELFN2 SH3BP4 GPC5 CSMD1 SEZ6L	9.35e-05	190	171	6	d146af1926474328a7c822bc140c4dda66e1bbfb
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 PDE2A ITGA9 PKHD1L1 PLOD1 BTNL9	9.35e-05	190	171	6	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MON2 FRYL HEATR1 ITGA4 TMEM30A DOP1B	9.63e-05	191	171	6	9454f642c3621370fa23640b631301346b300950
ToppCell	facs-BAT-Fat-18m-Endothelial\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PDE2A PRAG1 BTNL9 TNS1 PDZD2	9.91e-05	192	171	6	3a99c521c599a289ee2309d97be5ceb99f8aa220
ToppCell	facs-BAT-Fat-18m-Endothelial-endothelial_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PDE2A PRAG1 BTNL9 TNS1 PDZD2	9.91e-05	192	171	6	f9777e0fdd86c2a514f05a42502888329a94b396
ToppCell	3'_v3-bone_marrow-Lymphocytic_B\|bone_marrow / Manually curated celltypes from each tissue	PKHD1L1 PTPRK IGHD IGHE IGHM BTNL9	9.91e-05	192	171	6	8a284b6e499f5a3c116d5551430f00ecad4a3681
ToppCell	facs-BAT-Fat-18m-Endothelial-nan\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PDE2A PRAG1 BTNL9 TNS1 PDZD2	9.91e-05	192	171	6	562e15876088af9189744c9b2de5c4863d7f15fd
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NID2 HSPG2 ITGA9 E2F8 MSX1 DCHS1	9.91e-05	192	171	6	a42aed9e563f5f4af029b8804c104f11ad227a8f
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	COL7A1 DSG3 LAMA5 ITGB4 FAT1 PTPRK	9.91e-05	192	171	6	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MED13L PTPRK ATXN1 LRP2 DIP2C PDZD2	9.91e-05	192	171	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LAM-Endothelial-LymEndo\|LAM / Condition, Lineage and Cell class	NID2 PDE2A RET ITGA9 DYSF PKHD1L1	1.02e-04	193	171	6	68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	FRYL LATS1 GANAB PTPRK USP32 CPLANE1	1.02e-04	193	171	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ITGA9 ITGB4 MSX1 HMCN2 BTNL9	1.02e-04	193	171	6	cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	MON2 SPPL3 FAXDC2 MED13L PRAG1 PRAME	1.02e-04	193	171	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	droplet-Kidney-nan-21m-Endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PDE2A DRAM1 DYSF MSX1 BTNL9	1.02e-04	193	171	6	0e39b6c8e7382e61a9891f6c7e3df2a859788219
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A ITGA9 DYSF PKHD1L1 RADIL CYB5R3	1.05e-04	194	171	6	937ee85ffd50869b60f0f6e91017ab77e8b24c0b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PDE2A ITGA9 DYSF KCNN2 BTNL9	1.05e-04	194	171	6	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	Endothelial-A-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	HSPG2 ITGB4 OTC NLGN4X DCHS1 BTNL9	1.05e-04	194	171	6	e656ac5539e59e321b46706cb8cc423b2c3358a0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PDE2A ITGA9 DYSF HMCN2 BTNL9	1.08e-04	195	171	6	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	3'-Adult-LymphNode-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A ITGA9 PKHD1L1 OTC RADIL CYB5R3	1.11e-04	196	171	6	a2845436003e9adf34677eb81e78f8334ff01faa
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE2A C5orf67 ITGA9 DYSF PKHD1L1 RADIL	1.11e-04	196	171	6	09a7edf4a7defb7fe70d9777dd9500ee8421ff31
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE2A C5orf67 ITGA9 DYSF PKHD1L1 RADIL	1.11e-04	196	171	6	e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755
Drug	AC1L9732	CASS4 COL7A1 DSG3 TWNK GBA3 DCHS1 LRP2 SDHC	2.30e-06	114	170	8	CID000439300
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A	HDAC5 TRPC4 ZNF407 ITGA9 LATS1 BSN TNS1 PML DOP1B PDZD2	2.62e-06	199	170	10	6478_UP
Drug	oxamic acid sodium salt; Down 200; 10000uM; MCF7; HG-U133A	MYO9B PPFIA3 DYSF MSX1 PAPOLA BTD GMEB1 PAM MVP SEZ6L	2.62e-06	199	170	10	439_DN
Drug	kalinin	HSPG2 COL7A1 LAMA5 ITGA4 ITGB4 PAM	3.40e-06	55	170	6	CID000032518
Drug	Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; HL60; HT_HG-U133A	MYO9B SQLE IDS VPS13D ATXN1 PAM PLOD1 TNS1 TRIB1	6.64e-06	174	170	9	1276_DN
Drug	hexamethyldisiloxane	CASS4 DSG3 TWNK PACS2	8.46e-06	18	170	4	CID000024764
Drug	(+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA	MYO9B MARS1 FAXDC2 ZFX PAPOLA ATXN1 LRP2 MVP PML	1.59e-05	194	170	9	954_UP
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HSPG2 DMXL2 MYO9B PPFIBP2 FAXDC2 ITGB4 ZFX VPS13D PML	1.73e-05	196	170	9	2818_DN
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A	MYO9B FAXDC2 URB2 PTPN18 DIP2A VPS13D BTD LRP2 KCNN2	1.80e-05	197	170	9	2212_DN
Drug	Biotin [58-85-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A	CD248 FAXDC2 ITGA4 ITGB4 VPS13D SLC34A1 TMC5 HSF1 TNS1	1.87e-05	198	170	9	3289_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	MON2 ZNF407 SEMA6D SLC34A1 LRP2 C3AR1 TNS1 PML SYMPK	2.03e-05	200	170	9	3714_UP
Drug	Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A	COL7A1 IDS PTPN18 KLHL29 VPS13D ATXN1 BTD CPLANE1 PML	2.03e-05	200	170	9	6283_UP
Disease	colonic neoplasm, overall survival	DSG3 IDS PAPOLA	5.55e-05	14	161	3	EFO_0000638, EFO_0004288
Disease	aspartate aminotransferase measurement	C5orf67 BAG3 SPPL3 ITGA9 PIGU PTPN18 PRAG1 GBA3 HMCN2 ATXN1 ABCB11 IFT80 CSMD1 TRIB1 WNK2	1.36e-04	904	161	15	EFO_0004736
Disease	heart rate	SLC10A7 KLHL29 GBA3 SLC13A1 KIAA1755 CSMD1 PDZD2	2.47e-04	225	161	7	EFO_0004326
Disease	cutaneous melanoma, hair color	C5orf67 PPFIBP2 MED13L PIGU	3.72e-04	62	161	4	EFO_0000389, EFO_0003924
Disease	obsessive-compulsive disorder, Tourette syndrome	TRPC4 ACOD1 GBA3	3.78e-04	26	161	3	EFO_0004242, EFO_0004895
Disease	ETS domain-containing protein Elk-3 measurement	SLC35D2 PLOD1	4.37e-04	6	161	2	EFO_0801588
Disease	WAP four-disulfide core domain protein 3 measurement	SLC35D2 PLOD1	4.37e-04	6	161	2	EFO_0802220
Disease	acid ceramidase measurement	SLC35D2 PLOD1	4.37e-04	6	161	2	EFO_0801339
Disease	lon protease homolog, mitochondrial measurement	SLC35D2 PLOD1	4.37e-04	6	161	2	EFO_0801771
Disease	Bilateral Wilms Tumor	BCORL1 TRIP13 DROSHA	5.25e-04	29	161	3	C2930471
Disease	level of oxylipin in blood plasma	ITGA9 KIAA1755	6.10e-04	7	161	2	OBA_2050338
Disease	autosomal dominant polycystic kidney disease (biomarker_via_orthology)	SLC34A1 LRP2	6.10e-04	7	161	2	DOID:898 (biomarker_via_orthology)
Disease	interleukin-17 receptor B measurement	SLC35D2 PLOD1	6.10e-04	7	161	2	EFO_0801719
Disease	cesarean section, anxiety	ATXN1 DIP2C	8.11e-04	8	161	2	EFO_0005230, EFO_0009636
Disease	Scoliosis, unspecified	PIGU SLC10A7	8.11e-04	8	161	2	C0036439
Disease	benign neoplasm (implicated_via_orthology)	LATS1 LATS2	8.11e-04	8	161	2	DOID:0060072 (implicated_via_orthology)
Disease	asthma	ADAD1 DMXL2 MYO9B ACO1 SPPL3 DYSF PIGU PRAG1 PTPRK SLC34A1 USP32 SYMPK	8.94e-04	751	161	12	MONDO_0004979
Disease	citrate measurement	NLGN4X SLC34A1 TRIB1 WNK2	9.33e-04	79	161	4	EFO_0010114
Disease	C-reactive protein measurement	DMXL2 AHI1-DT C5orf67 CD248 SPPL3 PIGU PRAG1 ACOD1 LRRC55 RADIL LATS1 PAPOLA EIF2B4 ABCB11 BSN TRIB1	9.58e-04	1206	161	16	EFO_0004458
Disease	hypothyroidism (biomarker_via_orthology)	CYP19A1 SLC34A1 PAM PLOD1	9.78e-04	80	161	4	DOID:1459 (biomarker_via_orthology)
Disease	Nephroblastoma	BCORL1 TRIP13 DROSHA	9.97e-04	36	161	3	C0027708
Disease	glucose measurement	C5orf67 PPFIBP2 EIF2B4 KLHL42 ABCB11 PAM IFT80 BSN	1.20e-03	380	161	8	EFO_0004468
Disease	hippocampal volume	AHI1-DT MED13L PRAG1 SEMA6D ABCB11 PAM WNK2	1.27e-03	297	161	7	EFO_0005035
Disease	cryptorchidism (biomarker_via_orthology)	MSX1 HSF1	1.58e-03	11	161	2	DOID:11383 (biomarker_via_orthology)
Disease	kidney cancer (implicated_via_orthology)	LATS1 LATS2	1.58e-03	11	161	2	DOID:263 (implicated_via_orthology)
Disease	Non-Small Cell Lung Carcinoma	COL7A1 RET ITGB4 E2F8 PRAME	1.69e-03	156	161	5	C0007131
Disease	Malignant Head and Neck Neoplasm	FANCF FAT1 PRAME	1.79e-03	44	161	3	C0278996
Disease	Carcinoma, Neuroendocrine	RET SDHC	1.88e-03	12	161	2	C0206695
Disease	interleukin 7 measurement	TMEM260 DCHS1 PDZD2	1.91e-03	45	161	3	EFO_0008189
Disease	putamen volume change measurement	DCHS1 TMEM30A	2.22e-03	13	161	2	EFO_0021495
Disease	illegal drug consumption	ITGA9 CSMD1	2.22e-03	13	161	2	EFO_0005431
Disease	Adenoid Cystic Carcinoma	BCORL1 INSRR ITGB4 FAT1	2.23e-03	100	161	4	C0010606
Disease	cannabis dependence measurement	RET DIP2A CSMD1	2.30e-03	48	161	3	EFO_0008457
Disease	glycodeoxycholate measurement	COL7A1 CSMD1	2.58e-03	14	161	2	EFO_0010493
Disease	sulfate measurement	SLC13A1 SLC34A1	2.58e-03	14	161	2	EFO_0007864
Disease	cortical surface area measurement	MON2 SLC9A9 C5orf67 MYO9B FRYL MED13L DYSF PHC2 KLHL29 CHMP7 KIAA1755 PAM IGSF9 TNS1 WNK2 PDZD2	2.89e-03	1345	161	16	EFO_0010736
Disease	Carcinoma of Endocrine Gland	RET SDHC	2.97e-03	15	161	2	C1704374
Disease	waist-hip ratio	NID2 DMXL2 C5orf67 MYO9B CYP19A1 ZNF407 ITGA9 KLHL29 BTD NISCH PAM TRIB1 LRRC36 PML SYMPK	3.00e-03	1226	161	15	EFO_0004343
Disease	sexual dimorphism measurement	COL7A1 HDAC5 DRAM1 CD248 SLC35D2 MYO9B MARS1 CYP19A1 FRYL DYSF PIGU KLHL29 BSN TRIB1	3.05e-03	1106	161	14	EFO_0021796
Disease	estradiol measurement	CYP19A1 DHX57 ZNF407 PHC2	3.15e-03	110	161	4	EFO_0004697
Disease	Autistic Disorder	SLC9A9 CYP19A1 ITGA4 NLGN4X BTD PLA2G4A	3.18e-03	261	161	6	C0004352
Disease	inflammatory bowel disease	ADAD1 ITGA4 SEMA6D PTPRK SLC34A1 PLA2G4A BSN TRIB1	3.36e-03	449	161	8	EFO_0003767
Disease	Blood Platelet Disorders	MPIG6B PLA2G4A	3.38e-03	16	161	2	C0005818
Disease	phosphorus measurement	AHI1-DT SLC34A1	3.38e-03	16	161	2	EFO_0004861
Disease	heart failure	BAG3 ACAD10 DYSF PRAME SYMPK	3.54e-03	185	161	5	EFO_0003144
Disease	polyp of colon	NID2 LAMA5 ACAD10	3.58e-03	56	161	3	MONDO_0021400
Disease	cancer (implicated_via_orthology)	SQLE RET PHC2 NKX2-8 LATS1 LATS2	3.62e-03	268	161	6	DOID:162 (implicated_via_orthology)
Disease	Astrocytosis	ITGA4 ITGB4	3.81e-03	17	161	2	C3887640
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	FCRLB SDHC	3.81e-03	17	161	2	EFO_0021969
Disease	phosphatidylcholine 40:6 measurement	CSMD1 TMC5	3.81e-03	17	161	2	EFO_0010389
Disease	Gliosis	ITGA4 ITGB4	3.81e-03	17	161	2	C0017639
Disease	pulse pressure measurement	C5orf67 LAMA5 FRYL ACAD10 MED13L ITGA9 DYSF PHC2 KLHL29 DIP2A LATS2 ATXN1 KLHL42 ABCB11 KIAA1755 IFT80	4.03e-03	1392	161	16	EFO_0005763
Disease	insulin resistance	C5orf67 CSMD1 SEZ6L	4.14e-03	59	161	3	EFO_0002614
Disease	body composition measurement	C5orf67 TRPC4 DYSF HMCN2 TRIB1	4.23e-03	193	161	5	EFO_0005106
Disease	Osteochondrodysplasias	HSPG2 SLC10A7	4.76e-03	19	161	2	C0029422
Disease	Pheochromocytoma	RET SDHC	4.76e-03	19	161	2	C0031511
Disease	cleft lip	IL22RA2 SLC13A1 ATXN1 GPC5 CSMD1 TRIB1	4.80e-03	284	161	6	EFO_0003959
Disease	reticulocyte count	C5orf67 MYO9B CYP19A1 SPPL3 ITGA4 FAT1 ATXN1 NISCH USP32 BSN TNS1 TRIB1 PDZD2	4.92e-03	1045	161	13	EFO_0007986
Disease	urinary microalbumin measurement	MON2 KCNN2	5.27e-03	20	161	2	EFO_0010967
Disease	sphingomyelin 22:0 measurement	HEATR1 CSMD1	5.27e-03	20	161	2	EFO_0010395
Disease	Colorectal Carcinoma	COL7A1 CD248 RET FAT1 NLGN4X DCHS1 LRP2 DIP2C ABCB11 BPIFB2	5.34e-03	702	161	10	C0009402

Protein segments in the cluster

Peptide	Gene	Start	Entry
YIATQGPLPHTLLDF	PTPN18	101	Q99952
ISALQLDSLLPPYHV	URB2	901	Q14146
PPGSGIIHQVNLEYL	ACO1	171	P21399
IAYGSVVLQLHSIIP	BTNL9	111	Q6UXG8
HPAVYRLSLNASLPA	DISP3	841	Q9P2K9
ITVPPGHGVYINFTL	CSMD1	2176	Q96PZ7
LTYPSPAALGHLQAE	CASS4	756	Q9NQ75
VPSVGLTRILPHLYL	DUSP8	156	Q13202
DLPSAYQPGILSVSH	CD248	491	Q9HCU0
TYVGVANPVPASLLL	BCORL1	716	Q5H9F3
PGYRHHLIPSLSQII	CFAP46	146	Q8IYW2
LAHYLPSSFPVLRGI	ACAD10	501	Q6JQN1
SQLSYLVHEPPLAVV	ABCB11	701	O95342
GQFTVPHSLALVPLL	PAM	681	P19021
FYLVNRPHISLVPSA	ADAD1	446	Q96M93
TLVNTGHFLYLQPPA	AHI1-DT	216	P0C7V0
TSLPPLYRVQLLHQG	DMXL2	1581	Q8TDJ6
AITYAGSLPQHLVIP	ATXN1	471	P54253
VAAHLDALGPLVPYV	DEXI	6	O95424
TPYHIFGVLSLLTDP	C3AR1	391	Q16581
LTLLHNGEPLYIPVT	RAB3GAP1	626	Q15042
YPLSPTISLANGSHV	RBM46	506	Q8TBY0
SPQHILGLPVGQHIY	CYB5R3	66	P00387
PGLAQPIYIEASSSH	HSPG2	2921	P98160
THLGAPGLYIQTLLP	RADIL	996	Q96JH8
VLVSPSLSGHYALPF	ABHD14A	166	Q9BUJ0
VLSGHVNPFLPYISD	DRAM1	31	Q8N682
QIPPGVYHISLVLTD	DSG3	556	P32926
ITAIGNPINEPLFYH	FAT1	2001	Q14517
SVPLLIYHPAQILLG	SLC10A7	301	Q0GE19
IYHPAQILLGSVLVP	SLC10A7	306	Q0GE19
SYHILAGNSPPLFTL	DCHS1	721	Q96JQ0
SLAHNRITAVPPGYL	LRRC55	71	Q6ZSA7
RHPALSPVYLGLLTD	FANCF	266	Q9NPI8
QPIPEAHSLYVTLIL	MED13L	1101	Q71F56
VHTLPSGPQLFRYAT	GMEB1	436	Q9Y692
LAHSLVGTPNYIAPE	LATS1	906	O95835
HSLVGTPNYIAPEVL	LATS2	871	Q9NRM7
ILIVYSIPHGIQGPE	DTX2	506	Q86UW9
FPLVYNHLINPGVTD	GPC5	171	P78333
YSAISQLALGISHPP	IMPG1	486	Q17R60
LDTAIQHALAGLYPP	KIAA1755	6	Q5JYT7
ILVCAIHPIPGNYTF	KCNN2	221	Q9H2S1
SASHRYVLGVQVPPQ	HMCN2	1151	Q8NDA2
LYHLESGLSPPVAIF	MYG1	276	Q9HB07
LRYSQAPTLPSGAHL	PPFIA3	516	O75145
PVATVGIFATYLPDH	AQP7P3	151	A6NL99
AISALQYVQPHPLTS	DOP1B	1481	Q9Y3R5
PYINHPIGVARILTH	HDDC3	31	Q8N4P3
HLPLAGQASPQLYAA	BSN	2906	Q9UPA5
VHYTAQPLFLLDPGS	HSF1	466	Q00613
SSQIHPYQLPSDVGL	LRRC36	316	Q1X8D7
VAVPAALILGSYVHI	OR2Y1	206	Q8NGV0
PLHYPTILTNSVIGK	OR51L1	131	Q8NGJ5
RPLHYPALLTNGVIS	OR51S1	136	Q8NGJ8
SIPIINGLSDLYHPI	OTC	156	P00480
LALENSPPGIYIHSL	PDZD2	746	O15018
TTGQILNIPDAYAHP	PDE2A	471	O00408
YLSNGTLAAPVVVLP	FAM234B	251	A2RU67
DGVLSQLSPLPHLYS	FRYL	1251	O94915
NGSLLVILHAPNLPY	IL22RA2	171	Q969J5
TVYDGALPHPFAITI	LRP2	3401	P98164
TTIPRPSAYHNLFGL	TWNK	236	Q96RR1
PSAYHNLFGLPLISR	TWNK	241	Q96RR1
GLIFHLGQARTPPYL	LAMA5	3556	O15230
ISHQPTPVINSLAVY	NPIPB7	16	O75200
GSLPPHYALTVLNTT	MON2	611	Q7Z3U7
GLFPAYQHLASPALV	NKX2-8	221	O15522
PAAVLFVYTLHPSGE	OVOS2	516	Q6IE36
VIPLGSHPVARYLGS	PACS2	586	Q86VP3
LVHAGVPASYLLIPA	EIF2B4	376	Q9UI10
HAASINPTELVPYGL	ITGB4	806	P16144
ISHQPTPVINSLAVY	NPIPB15	16	A6NHN6
SPYSGAVFHETPLII	PIGU	56	Q9H490
VPITTLGPHNYCVIL	MVP	271	Q14764
AALLSQIPGPTAAYI	PPFIBP2	71	Q8ND30
LAYDTLPVLIHGNGP	PLOD1	231	Q02809
LPFLAHALYVQAPTV	TRIP13	391	Q15645
QVLHRIPGTSAYAFP	SLC34A1	36	Q06495
PQKHYGITSPISLAA	PAPOLA	16	P51003
LPLPVFTVRHYAGTV	MYO15B	141	Q96JP2
YTAISHIPQPAAQAL	NID2	566	Q14112
ILPHGFCYIIPSNLQ	ITGA9	156	Q13797
ITPATYHIAFGPVID	NLGN4Y	331	Q8NFZ3
APIGVISLYAHPIEH	FAXDC2	211	Q96IV6
ADGSLVHISITPYPA	IFT80	576	Q9P2H3
HGYQSLPELVLVPAQ	C5orf67	21	F2Z3F1
NHRIYSSPIAGVIPV	E2F8	666	A0AVK6
PQAPGRYFAHSILTV	IGHM	386	P01871
LNPIHYNITSIVPEA	CYP19A1	6	P11511
PAGNTHLYLLSTPSV	CPLANE1	2191	Q9H799
GVTPIVTLYHFDLPQ	GBA3	111	Q9H227
LYQNSPLSSHPVVAL	CHMP7	166	Q8WUX9
RLTPLGYHLASLPVD	DHX57	1051	Q6P158
LYNGITPVPLSGLIH	FAM111A	456	Q96PZ2
IGSNRPLSPHITIYS	SDHC	46	Q99643
HAELILANPSPVLIY	SQLE	321	Q14534
NSPVVLACLITGYHP	IGHD	21	P01880
VALQVQVLDTPGYPH	GIMD1	66	P0DJR0
VYSGHQSILIPPSEL	DIP2C	1196	Q9Y2E4
AVYEHPSILSLNPLA	BTD	61	P43251
PTVARAYPLVGHALL	CYP4V2	51	Q6ZWL3
DLHPTLPAGRYSLNV	TMEM30A	281	Q9NV96
HFPPTIQLLCLVSGY	IGHE	126	P01854
ILTPIQIEAAYHLGP	ITGA4	571	P13612
VHLALLPPGNYSARV	INSRR	876	P14616
LPPTYAAFVNGVAIH	ACOD1	76	A6NK06
VYSTEPLISQHLPAG	KRTAP23-1	36	A1A580
PYLPVLATSGLDQHV	DCAF8L1	491	A6NGE4
VQVGLLSYSHRPSPL	COL7A1	1091	Q02388
LPHFISPYLEGILSQ	HEATR1	1771	Q9H583
HVPLIFYVPGRTASL	IDS	356	P22304
VYSGHQSVLVPPLEL	DIP2A	1211	Q14689
GYHPLLLELQPISTL	FCRLB	46	Q6BAA4
VYQAPLSLATVPHQA	HDAC5	641	Q9UQL6
LGSHQLPRGYISIPV	BAG3	196	O95817
VLPQINLDHYSVLPA	DHX37	531	Q8IY37
VGAVLLTGIAYSLPH	SLC22A14	281	Q9Y267
LSPLAEAIHVNPLYI	SLC13A1	501	Q9BZW2
EAIHVNPLYILIPST	SLC13A1	506	Q9BZW2
SLVLQVSYTPLPGAV	DYSF	116	O75923
ITPATYHIAFGPVID	NLGN4X	331	Q8N0W4
TPGLVYSIPFDHIVL	MUCL3	51	Q3MIW9
SPYQTGQLHPAIRVA	PTPRK	856	Q15262
LVGPPSLVLVSYSHI	OR2A1;	206	Q8NGT9
PGLYVLPSTVGFINH	ODF3L2	46	Q3SX64
HVVDSGLTFNLPYPL	PLA2G4A	546	P47712
PLHYATILTSQVLVG	OR52J3	131	Q8NH60
NHIYQGTLELPTPLI	SZT2	3091	Q5T011
IPLYKTLQTVGPSHA	DROSHA	1281	Q9NRR4
PLPLLYVGNHISGLS	SLC35D2	96	Q76EJ3
VHNATIGRVLSPSYP	SEZ6L	456	Q9BYH1
IGLSNLTHVLYPVPL	PRAME	431	P78395
NVLLPPIIFHAGYSL	SLC9A9	136	Q8IVB4
VAVVAHGPSILYPST	SH3BP4	451	Q9P0V3
LGPAYLRLGPHTILS	SLC25A34	271	Q6PIV7
AALPVAPVGLYTAHV	MSX1	281	P28360
VLHLGLPPSFESYVQ	RECQL4	786	O94761
LLEVSPGPQLAQHVY	PML	756	P29590
HGPQTLYLPVTLSSI	GANAB	786	Q14697
HGSVYPQLLIPLLGA	MPIG6B	136	O95866
DSPHLILYPAIVGTI	SMG1	1851	Q96Q15
APLPHYLGASVIITN	SIM2	651	Q14190
ALPIQAAQHSPYVAL	ABHD1	336	Q96SE0
IALPGVVNLHYVAPE	BPIFB2	426	Q8N4F0
AVAAHPLIAPAYAQL	PHC2	316	Q8IXK0
IRPYIQLPSHSNITG	TRIB1	131	Q96RU8
LVLILTPSLAAYRHP	ERVFRD-1	6	P60508
HRAAQPALLYLVPFT	SPPL3	336	Q8TCT6
SALVYQHSIIPLALP	TNS1	1551	Q9HBL0
HVSLLNNPLSIIPDY	NISCH	406	Q9Y2I1
ITYIRAHTNLPGPLT	ERVK-10	561	P10266
LAQTALTVVALPPGY	TMEM186	76	Q96B77
IVQHSSPPGLIVTSY	TEX101	91	Q9BY14
PILTQFTPYLGHLRN	PRAMEF11	221	O60813
PLNYTHLGITVTLPD	PKHD1L1	2361	Q86WI1
GLLHPPSASAYLTVL	IGSF9	306	Q9P2J2
PALSLYSPGLQQLAH	PRAG1	1291	Q86YV5
QAYETLHANLPPTLA	SYMPK	276	Q92797
AGTPLLYVHALRDAP	RET	46	P07949
TAIIIGPDGHPLTVY	ZFX	411	P17010
NIHYPLRVALSSIQP	ZBED9	1296	Q6R2W3
HPDQVFPLASSLYGI	ZBTB2	121	Q8N680
HSNPGAVLLLPFVVS	TMC5	651	Q6UXY8
GTTHYILTELPPGVQ	ZNF407	2166	Q9C0G0
SQILLGHPAPYAVDV	WNK2	1021	Q9Y3S1
VGIHLQTQTPDLYPV	TMEM207	111	Q6UWW9
YIQGTPVSVHLQPSL	SEMA6D	1011	Q8NFY4
VLITSALPYVNNVPH	MARS1	266	P56192
SLPDSPFTGYIIAVH	USP32	1066	Q8NFA0
PDITPIILAAHTNNY	TRPC4	141	Q9UBN4
FSAGLLPYVHLPISS	TMEM260	226	Q9NX78
LLVPRPYHSLNAITV	ELFN2	226	Q5R3F8
FRQPGHTIYLLPTVV	VPS13D	3171	Q5THJ4
AVVRLPFIHPSYLLN	KLHL29	521	Q96CT2
PAFGHNLLVSSLYLP	KLHL42	486	Q9P2K6
QIHSVYITPGADLPV	MYO9B	2106	Q13459
AALTVPSHPYGITLL	MYOM2	706	P54296